JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 3 No. 12, December 1994 TABLE OF CONTENTS
  Archives
 • Online Features
  Letters to the Editor
 This Article
 •Excerpt
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Pharmacoeconomic Considerations in Pharmaceutical Company Promotions-Reply

Richard Levy, PhD

Arch Fam Med. 1994;3(12):1035.


References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.



1. Levy RA. Pharmaceutical Research: Therapeutic and Economic Value of Incremental Improvements. Reston, Va: National Pharmaceutical Council; 1990.
2. Yasuda SA, Woosley RL. The clinical value of FDA class C drugs approved from 1981 to 1988. Clin Pharmacol Ther. 1992;52:577-582. PUBMED